Search

everythinglearnresearchcommunity

for

Search:↓

More than half of patients who had acromegaly surgery experienced hair loss, with varying degrees of recovery.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Some breast cancer chemotherapy can cause permanent hair loss.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Finasteride affects prostate weights and pituitary activity differently with age.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

PCOS may increase the risk of certain cancers.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Herbal remedies can cause adverse effects and need more safety research.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Lgr5 is a marker for active, self-renewing stem cells in the intestine and skin, important for tissue maintenance.